We help innovative pharmaceutical companies and biotechs optimize the lifetime performance of their Intellectual property in the current environment of depleted R&D pipelines, cost containment and more aggressive generic competition.
Biotech & Pharma IP evaluation:
We offer the following interrelated services:
- Advice on setting up and implementing excellent lifecycle management (LCM) structures, systems and processes
- Training of project and brand teams in LCM
- Brand and project audits to ensure that LCM plans are comprehensive, realistic and sustainable
- Evaluation and valuation of individual patent portfolios, and advice on how to strengthen and / or prolong patent protection of brands
Our Experienced IPEG team members with a solid expertise in Pharma & Biotech Governance & Pharmaceutical Lifecycle Management:
![]() |
![]() |
![]() |
![]() |
![]() |